Polymeric microspheres for medical applications

Materials

Volumn 3, Issue 6, 2010, Pages 3537-3564

  Saralidze, Ketie ^a   Koole, Leo H ^a   Knetsch, Menno L W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bulking agent; Drug delivery; Embolization; Microspheres; Polymer

Indexed keywords

BULKING AGENTS; DIFFERENT TREATMENTS; EMBOLIZATION; LARGE ARRAYS; POLYMERIC MICROSPHERE;

FUNCTIONAL POLYMERS; MEDICAL APPLICATIONS; POLYMERS; WASTE MANAGEMENT;

MICROSPHERES;

EID: 79960748343     PISSN: None     EISSN: 19961944     Source Type: Journal    
DOI: 10.3390/ma3063537     Document Type: Review

References (171)

1. Eppley, B.L.; Dadvand, B. Injectable soft-tissue fillers: clinical overview. Plast. Reconstr. Surg. 2006, 118, e98-e106.
2. Laeschke, K. Biocompatibility of microparticles into soft tissue fillers. Semin. Cutan. Med. Surg. 2004, 23, 214-217.
3. Amrute, K.V.; Badlani, G.H. The science behind biomaterials in female stress urinary incontinence surgery. Sci. World J. 2009, 9, 23-31.
4. Broder, K.W.; Cohen, S.R. An overview of permanent and semipermanent fillers. Plast. Reconstr. Surg. 2006, 118 (suppl.), S7-S14.
5. Garvin, K.; Feschuk, C. Polylactide-polyglycide antibiotic implants. Clin. Orthop. Relat. Res. 2005, 437, 105-110.
6. Starkman, J.S.; Scarpero, H.; Dmochowski, R.R. Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better? Curr. Urol. Rep. 2006, 7, 405-413.
7. Kotb, A.F.; Campeau, L.; Corcos, J. Urethal bulking agents: techniques and outcomes. Curr. Urol. Rep. 2009, 10, 396-400.
8. Dmochowski, R.R.; Appell, R.A. Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology 2000, 56 (6 suppl. 1), 32-40.
9. Laurent, A. Microspheres and nonspherical particles for embolization. Tech. Vasc. Interv. Radiol. 2007, 10, 248-256.
10. David, M.; Ebert, A.D. Treatment of uterine fibroids by embolization-advantages, disadvantages, and pitfalls. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005, 123, 131-138.
11. Kettenbach, J.; Stadler, A.; Katzler, I.; Schernthaner, R.; Blum, M.; Lammer, J.; Rand, T. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc. Intervent. Radiol. 2008, 31, 468-476.
12. Yu, L.; Ding, J. Injectable hydrogels as unique biomedical materials. Chem. Soc. Rev. 2008, 37, 1473-1481.
13. Chitkara, D.; Shikanov, A.; Kumar, N.; Domb, A.J. Biodegradable injectable in situ depot-forming drug delivery systems. Macromol. Biosci. 2006, 6, 977-990.
14. Packhadieuser, C.B.; Schnieders, J.; Oster, C.G.; Kissel, T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 2004, 58, 445-455.
15. Wischle, C.; Schwendeman, S.P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 2008, 364, 298-327.
16. Freiberg, S.; Zhu, X.X. Polymer microspheres for controlled drug release. Int. J. Pharm. 2004, 282, 1-18.
17. Varde, N.K.; Pack, D.W. Microspheres for controlled release drug delivery. Exp. Opin. Biol. Ther. 2004, 4, 35-51.
18. Nicolini, A.; Martinetti, L.; Crespi, S.; Maggioni, M.; Sangiovani, A. Transarterial chemoembolization with epirubicin-eluting beads versus trransarterial embolization before liver transplantation for hepatocellular carcinoma. J. Vasc. Interven. Radiol. 2010, 21, 327-332.
19. Cavalieri, F.; Chiessi, E.; Villa, R.; Vigano, L.; Zaffaroni, N.; Telling, M.F.; Paradossi, G. Novel PVA-based hydrogel microparticles for doxorubicin delivery. Biomacromolecules 2008, 9, 1967-1973.
20. Saralidze, K.; Knetsch, M.L.W.;van Hooy-Corstjens, C.S.J.; Koole, L.H. Radio-opaque and surface-functionalized polymer microparticles: potentially safer biomaterials for different injection therapies. Biomacromolecules 2006, 7, 2991-2996.
21. Arshady, R. Preparation of polymer nano- and microspheres by vinyl polymerization techniques. J. Microencapsul. 1988, 5, 101-114.
22. Cao, Y.; Tian, W.; Gao, S.; Yu, Y.; Yang, W.; Bai, G. Immobilization staphylococcal protein a on magnetic cellulose microspheres for IgG affinity purification. Artif. Cells Blood Substit. Immobil. Biotechnol. 2007, 35, 467-480.
23. Chilian, W.M.; Eastham, C.L.; Layne, S.M.; Marcus, M.L. Small vessel phenomena in the coronary microcirculation: phasic intramyocardial perfusion and coronary microvascular dynamics. Progr. Cardiovasc. Dis. 1988, 31, 17-38.
24. Quinones, A.; Cheirif, B.J. New perspectives for perfusion imaging echocardiography. Circulation 1991, 83 (suppl. 5), III104-III110.
25. Hong, S.J.; Yu, H.S.; Kim, H.W. Preparation of porous bioactive ceramic microspheres and in vitro osteoblastic culturing for tissue engineering application. Acta Biomater.2009, 5, 1725-1731.
26. Yaparpalvi, R.; Loyalka, S.K.; Tompson, R.V., Jr. Production of spherical ZrO2-Y2O3 and ZnO particles. J. Biomed. Mater. Res. 1994, 28, 1087-1093.
27. Sinha, V.R.; Bansal, K.; Kaushik, R.; Kumria, R.; Trehan, A. Poly-e-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 2004, 278, 1-23.
28. Li, M.; Rouaud, O.; Poncelet, D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int. J. Pharm. 2008, 363, 26-39.
29. Saralidze, K.; Aldenhoff, Y.B.J.; Knetsch, M.L.W., Koole, L.H. Injectable polymeric microspheres with X-ray visibility. Preparation, properties, and potential utility as new traceable bulking agents. Biomacromolecules 2003, 4, 793-798.
30. Gorodetsky, S.N.; Marx, G.; Gal, D.; Rivkin, R.; Ben-Ari, A.; Landsman, A.; Haviv, Y.S. Fibrin microbeads (FMB) as a 3D platform for kidney gene and cell therapy. Kidney Int. 2006, 69, 625-633.
31. Gorodetsky, R.; Clark, R.A.; An, J.; Gailit, J.; Levdansky, L.; Vexler, A.; Berman, E.; Marx, G. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. J. Invest. Dermatol. 1999, 112, 866-872.
32. Sengel, C.T.; Hascicek, C.; Gönül, N. Development and in vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride. J. Microencapsul. 2006, 23, 135-152.
33. Varshosaz, J. The promise of chitosan microspheres in drug delivery systems. Expert Opin. Drug Deliv. 2007, 4, 263-273.
34. Changerath, R.; Nair, P.D.; Mathew, S.; Nair, C.P.R. Poly(ethyl methacrylate)-grafted chitosan microspheres for controlled release of ampicillin. J. Biomed. Mater. Res. Part B: Appl. Biomater. 2008, 89B, 65-76.
35. Gupta, P.K.; Hung, C.T. Albumin microspheres I: physico-chemical characteristics. J. Microencapsul. 1989, 6, 427-462.
36. Thakkar, H.; Sharma, R.K.; Mishra, A.K.; Chuttani, K.; Murhty, R.R. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS Pharm. Sci. Tech. 2005, 6, E65-E73.
37. Bitz, C.; Doelker, E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int. J. Pharm. 1996, 131, 171-181.
38. Witschi, C.; Doelker, E. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. J. Control. Release1998, 51, 327-341.
39. Giunchedi, P.; Alpar, H.O.; Conte, U. PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods. J. Microencapsul. 1998, 15, 185-195.
40. Sivakumar, M.; Panduranga Rao, K. Synthesis, characterization, and in vitro release of ibuprofen from poly(MMA-HEMA) copolymeric core-shell hydrogel microspheres for biomedical applications. J. Appl. Polym. Sci. 2002, 83, 3045-3054.
41. Jayakrishnan, A.; Thanoo, B.C. suspension polymerization of 2-hydroxyethyl methacrylate in the presence of polymeric diluents: a novel route to spherical highly porous beads for biomedical applications. J. Biomed. Mater. Res. 1990, 24, 913-927.
42. Watts, P.J.; Davies, M.C.; Melia, C.D. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit. Rev. Ther. Drug Carrier Syst. 1990, 7, 235-259.
43. Ahmad, H.; Upin, D.; Armes, S.P.; Lewis, A.L. Synthesis of biocompatible sterically-stabilized poly(2-(methacryloyloxy)ethyl posphorylcholine) latexes via dispersion polymerization in alcohol/water mixtures. Langmuir 2009, 25, 11442-11449.
44. Piskin, E.; Tuncel, A.; Denizli, A.; Ayhan, H. Monosize microbeads based on polystyrene and their modified forms for some selected medical and biological applications. J. Biomater. Sci. Polym. Ed. 1994, 5, 451-471.
45. Ruckenstein, E.; Sun, Y. Preparation and characteristics of polymer-based large adsorbent particles. J. Appl. Polym. Sci. 1996, 61, 1949-1956.
46. Ruckenstein, E.; Hong, L. Sedimentation polymerization. Polymer 1995, 36, 2857-2860.
47. Williams, D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29, 2941-2953.
48. Fournier, E.; Passirani, C.; Montero-Menei, C.N.; Benoit, J.P. Biocompatibility of implantable synthetic polymerc drug crriers: focus on brain biocompatibility. Biomaterials 2003, 24, 331-3331.
49. Christensen, L.H. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol. Surg. 2009, 35 (Suppl. 2), 1612-1619.
50. Kusin, S.; Lippitz, J. Skin fillers. Dis. Month 2009, 55, 236-256.
51. Segall, L.; Ellis, D.A.F. Therapeutic options for lip augmentation. Facial Plast. Surg. Clin. N. Am. 2007, 15, 485-490.
52. Keegan, P.E.; Atiemo, K.; Cody, J.D.; McClinton, S.; Pickard, R. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst. Rev. 2007, 3, No. CD003881.
53. Appell, R.A.; Dmochowski, R.R.; Herschorn, S. Urethral injections for female stress incontinence. BJU Int. 2006, 98 (Suppl. 1), 27-30.
54. Herschorn, S. Current role of injectable agents for female stress urinary incontinence. Can. J. Urol. 2006, 13 (suppl.1), 5-12.
55. Saralidze, K.; van Hooy-Corstjens, C.S.J.; Koole, L.H.; Knetsch, M.L.W. New acrylic microspheres for arterial embolization: combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation. Biomaterials 2007, 28, 2457-2464.
56. van Hooy-Corstjens, C.S.J.; Saralidze, K.; Knetsch, M.L.W.; Emans, P.J.; de Haan, M.W.; Magusin, P.C.; Mezari, B.; Koole, L.H. New intrinsically radiopaque hydrophilic microspheres for embolization: synthesis and characterization. Biomacromolecules 2008, 9, 84-90.
57. Abrams, P.; Cardozo, L.; Fall, M.; Griffiths, D.; Rosier, P.; Ulmsten, U.; Van Kerrebroeck, P.; Victor, A.; Wein, A. Standardization Sub-Committee of the International Continence Society. The standardization of terminology in lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Urology 2003, 61, 37-49.
58. Breasted, J.H. Edwin Smith surgical papyrus in facsimile and hieroglyphic transliteration with translation and commentary; University of Chicago Oriental Institute: Chicago, IL, USA, 1930.
59. Ebbel, B. The papyrus Ebers: The greatest Egyptian medical document; Levin & Munksgaard: Copenhagen, Denmark, 1937.
60. Kegel, A.H. Progressive resistance exercise in the functional restoration of the perineal muscles. Am. J. Obste. Gynecol. 1948, 56, 238-248.
61. Cammu, H.; Van Nylen, M.; Amy, J. A ten-year follow-up after Kegel pelvic floor muscle exercises for genuine stress incontinence. BJU Int. 2000, 85, 655-658.
62. Hay-Smith, E.J.; Dumoulin, C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst. Rev. 2006, 25, CD005654.
63. Bo, K. Pelvic floor muscle training is effective in treatment of female stress urinary incontinence, but how does it work? Int. Urogynecol. J. Pelvic Floor Dysfunct. 2004, 15, 76-84.
64. Oelke, M.; Roovers, J.P.; Michel, M.C. Safety and tolerability of duloxetine in women with stress urinary incontinence. Br. J. Obstet. Gynaecol. 2006, 113 (Suppl 1), 22-26.
65. Guay, D.R. Duloxetine for management of stress urinary incontinence. Am. J. Geriatr. Pharmacother. 2005, 3, 25-38.
66. Mariappan, P.; Ballantyne, Z.; N'Dow, J.M.; Alhasso, AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst. Rev. 2005, 3, CD004742.
67. Mariappan, P.; Alhasso, A.; Ballantyne, Z.; Grant, A.; N'Dow, J. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur. Urol. 2007, 51, 67-74.
68. van Kerrebroeck, P.; Abrams, P.; Lange, R.; Slack, M.; Wyndaele, J.J.; Yalcin, I.; Bump, R.C. Duloxetine Urinary Incontinence Study Group. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. Br. J. Obstet. Gynaecol. 2004, 111, 249-257.
69. Lenzer, J. FDA warns that antidepressants may increase suicidality in adults. BMJ 2005, 331, 70.
70. Ulmsten, U.; Henriksson, L.; Johnson, P.; Varhos, G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1996, 7, 81-85.
71. Comiter, C.V. Surgery insight: management of failed sling surgery for female stress urinary incontinence. Nat. Clin. Pract. Urol. 2006, 3, 666-674.
72. Flock, F.; Reich, A.; Muche, R.; Kreienberg, R.; Reister, F. Hemorrhagic complications associated with tension-free vaginal tape procedure. Obstet. Gynecol. 2004, 104, 989-994.
73. Amundsen, C.L.; Flynn, B.J.; Webster, G.D. Urethral erosion after synthetic and nonsynthetic pubovaginal slings: differences in management and continence outcome. J. Urol. 2003, 170, 134-137.
74. Madjar, S.; Tchetgen, M.B.; van Antwerp, A.; Abdelmalak, J.; Rackley, R.R. Urethral erosion of tension-free vaginal tape. Urology 2002, 59, 601.
75. Abdel-Fattah, M.; Sivanesan, K.; Ramsay, I.; Pringle, S.; Bjornsson, S. How common are tape erosions? A comparison of two versions of the transobturator tension-free vaginal tape procedure. BJU Int. 2006, 98, 594-598.
76. Yamada, B.S.; Govier, F.E.; Stefanovic, K.B.; Kobashi, K.C. High rate of vaginal erosions associated with the mentor ObTape. J. Urol. 2006, 176, 651-654.
77. Siegel, A.L. Vaginal mesh extrusion associated with use of Mentor transobturator sling. Urology 2005, 66, 995-999.
78. Comiter, C.V.; Colegrove, P.M. High rate of vaginal extrusion of silicone-coated polyester sling. Urology 2004, 63, 1066-1070.
79. Govier, F.E.; Kobashi, K.C.; Kuznetsov, D.D.; Comiter, C.; Jones, P.; Dakil, S.E; James, R., Jr. Complications of transvaginal silicone-coated polyester synthetic mesh sling. Urology 2005, 66, 741-745.
80. Frederick, R.W.; Carey, J.M.; Leach, G.E. Osseous complications after transvaginal bone anchor fixation in female pelvic reconstructive surgery: report from single largest prospective series and literature review. Urology 2004, 64, 669-674.
81. Goldberg, R.P.; Tchetgen, M.B.; Sand, P.K.; Koduri, S.; Rackley, R.; Appell, R.; Culligan, P.J. Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. Urology 2004, 63, 704-708.
82. Mayer, R.D.; Dmochowski, R.R.; Appell, R.A.; Sand, P.K.; Klimberg, I.W.; Jacoby, K.; Graham, C.W.; Snyder, J.A.; Nitti, V.W.; Winters, J.C. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology 2007, 69, 876-880.
83. Chapple, C.R.; Haab, F.; Cervigni, M.; Dannecker, C.; Fianu-Jonasson, A.; Sultan, A.H. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur. Urol. 2005, 48, 488-494.
84. van Kerrebroeck, P.; ter Meulen, F.; Larsson, G.; Farrelly, E.; Edwall, L.; Fianu-Jonasson, A. Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 2004, 64, 276-281.
85. Abdelwahab, H.A.; Ghoniem, G.M. Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer. Int. Urogynecol. J. 2007, 18, 1379-1380.
86. Castillo-Vico, M.T.; Checa-Vizcaíno, M.A.; Payà-Panadés, A.; Rueda-García, C.; Carreras-Collado, R. Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence. Int. Urogynecol. J. 2007, 18, 95-97.
87. Lee, P.E.; Kung, R.C.; Drutz, H.P. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J. Urol. 2001, 165, 153-158.
88. Andersen, R.C. Long-term follow-up comparison of durasphere and contigen in the treatment of stress urinary incontinence. J. Low Genit. Tract. Dis. 2002, 6, 239-243.
89. Chrouser, K.L.; Fick, F.; Goel, A.; Itano, N.B.; Sweat, S.D.; Lightner, D.J. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J. Urol. 2004, 171, 1152-1155.
90. Hurtado, E.; McCrery, R.; Appell, R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2007, 18, 869-873.
91. Erekson, E.A.; Sung, V.W.; Rardin, C.R.; Myers, D.L. Ethylene vinyl alcohol copolymer erosions after use as a urethral bulking agent. Obstet. Gynecol. 2007, 109, 490-492.
92. Maher, C.F.; O'Reilly, B.A.; Dwyer, P.L.; Carey, M.P.; Cornish, A.; Schluter, P. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. Br. J. Obstet. Gynaecol. 2005, 112, 797-801.
93. Radley, S.C.; Chapple, C.R.; Mitsogiannis, I.C.; Glass, K.S. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency. Eur. Urol. 2001, 39, 383-389.
94. Tamanini, J.T.; D'Ancona, C.A.; Netto, N.R. Treatment of intrinsic sphincter deficiency using the Macroplastique Implantation System: two-year follow-up. J. Endourol. 2004, 18, 906-911.
95. Kulkarni, S.; Davies, A.J.; Treurnicht, K.; Dudderidge, T.J.; Al-Akraa, M. Misplaced Macroplastique injection presenting as a vaginal nodule and a bladder mass. Int. J. Clin. Pract. Suppl. 2005, 147, 85-86.
96. Peeker, R.; Edlund, C.; Wennberg, A.L.; Fall, M. The treatment of sphincter incontinence with periurethral silicone implants (macroplastique). Scand. J. Urol. Nephrol. 2002, 36, 194-198.
97. Malizia, A.A.; Reiman, H.M.; Myers, R.P.; Sande, J.R.; Barham, S.S.; Benson, R.C.; Dewanjee, M.K.; Utz, W.J. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984, 251, 3277-3281.
98. Kiilholma, P.J.; Chancellor, M.B.; Makinen, J.; Hirsch, I.H.; Klemi, P.J. Complications of Teflon injection for stress urinary incontinence. Neurourol. Urodyn. 1993, 12, 131-137.
99. Dewan, P.A.; Owen, A.J.; Byard, R.W. Long-term histological response to subcutaneously injected Polytef and Bioplastique in a rat model. Br. J. Urol. 1995, 76, 161-164.
100. Dewan, P.A. Is injected polytetrafluoroethylene (Polytef) carcinogenic? Br. J. Urol. 1992, 69, 29-33.
101. Beavan, A. Material properties and applications of Pyrolite™ Carbon. Mater. Eng. 1990, 77, 39-41.
102. Lightner, D.; Calvosa, C.; Andersen, R.; Klimberg, I.; Brito, C.G.; Snyder, J.; Gleason, D.; Killion, D.; Macdonald, J.; Khan, A.U.; Diokno, A.; Sirls, L.T.; Saltzstein, D. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 2001, 58, 12-15.
103. Lemperle, G.; Morhenn, V.B.; Pestonjamasp, V.; Gallo, R.L. Migration studies and histology of injectable microspheres of different sizes in mice. Plast. Reconstr. Surg. 2004, 113, 1380-1390.
104. Pannek, J.; Brands, F.H.; Senge, T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J. Urol. 2001, 166, 1350-1353.
105. Hartanto, V.H.; Lightner, D.J.; Nitti, V.W. Endoscopic evacuation of Durasphere. Urology 2003, 62, 135-137.
106. US Food and Drug Administration, Center for Devices and Radiological Health: Summary of safety and effectiveness data: Durasphere™ injectable bulking agent, 1999. Available at: www.fda.gov/cdrh/pdf/p980053.html (accessed April 2007).
107. Madjar, S.; Sharma, A.K.; Waltzer, W.C.; Frischer, Z.; Secrest, .L. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J. Urol. 2006, 175, 1408-1410.
108. Ghoniem, G.M.; Khater, U. Urethral prolapse after durasphere injection. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2006, 17, 297-298.
109. Madjar, S.; Covington-Nichols, C.; Secrest, C.L. New periurethral bulking agent for stress urinary incontinence: modified technique and early results. J. Urol. 2003, 170, 2327-2329.
110. Chrouser, K.L.; Fick, F.; Goel, A.; Itano, N.B.; Sweat, S.D.; Lightner, D.J. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J. Urol. 2004, 171, 1152-1155.
111. ®, injectable implant for soft tissue augmentation, November 10, 2005. Available at: http://www.fda.gov/cdrh/PDF4/p040047b.pdf (accessed April 2007).
112. ®, injectable dermal filler, December 22, 2006. Available at: http://www.fda.gov/cdrh/pdf5/p050037.html (accessed April 2007).
113. Mayer, R.; Lightfoot, M.; Jung, I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 2001, 57, 434-438.
114. Lemperle, G.; Morhenn, V.; Charrier, U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet. Plast. Surg. 2003, 27, 354-366.
115. Onol, F.F.; Tarcan, T.; Tinay, I.; Kotiloglu, E.; Simsek, F. Kidney loss due to periureteral fibrosis and ureteral obstruction secondary to migration of subureterically injected calcium hydroxylapatite. J. Pediat. Urol. 2006, 2, 503-508.
116. Palma, P.C.; Riccetto, C.L.; Martins, M.H.; Herrmann, V.; de Fraga, R.; Billis, A.; Netto, N.R., Jr. Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2006, 17, 670-671.
117. Stedman, T. Stedman's medical dictionary, 27th ed.; Lippincott Williams & Wilkins: Baltimore, MD, USA, 2000.
118. Coldwell, D.M.; Stokes, K.R.; Yakes, W.F. Embolotherapy: agents, clinical applications, and techniques. Radiographics 1994, 14, 623-643.
119. Ramsey, D.E.; Geschwind, J.F. New interventions for liver tumors. Semin. Roentgenol. 2002, 37, 303-311.
120. Agnelli, G.; Becattini, C. Venous thromboembolism and atherosclerosis: common denominators or different diseases? J. Thromb. Haemost. 2006, 4, 1886-1890.
121. Eliasson, A.; Bergqvist, D.; Björck, M.; Acosta, S.; Sternby, N.H.; Ogren, M. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies. J. Thromb. Haemost. 2006, 4, 1897-1902.
122. Prandoni, P.; Ghirarduzzi, A.; Prins, M.H.; Pengo, V.; Davidson, B.L.; Sørensen, H.; Pesavento, R.; Iotti, M.; Casiglia, E.; Iliceto, S.; Pagnan, A.; Lensing, A.W. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J. Thromb. Haemost. 2006, 4, 1891-1896.
123. Turpie, A.G. Preventing thromboembolism in patients with prosthetic heart valves. Cardiol. Clin. 1994, 12, 487-493.
124. Al-Mubarak, N.; Roubin, G.S.; Vitek, J.J.; Iyer, S.S. Microembolization during carotid stenting with the distal-balloon antiemboli system. Int. Angiol. 2002, 21, 344-348.
125. Liapi, E.; Geschwind, J.F. Transcatheter and ablative therapeutic approaches for solid malignancies. J. Clin. Oncol. 2007, 25, 978-986.
126. Lupattelli, T.; Basile, A.; Garaci, F.G.; Simonetti, G. Percutaneous uterine artery embolization for the treatment of symptomatic fibroids: current status. Eur. J. Radiol. 2005, 54, 136-147.
127. Helmberger, T.K.; Jakobs, T.F.; Reiser, M.F. Embolization of uterine fibroids. Abdom. Imaging 2004, 29, 267-277.
128. Yoon, W. Embolic agents used for bronchial artery embolization in massive haemoptysis., Exp. Opin. Pharmacother. 2004, 5, 361-367.
129. Funaki, B. Superselective embolization of lower gastrointestinal hemorrhage: a new paradigm. Abdom. Imaging 2004, 29, 434-438.
130. Hsu, A.A. Thoracic embolotherapy for life-threatening haemoptysis: a pulmonologist's perspective. Respirology 2005, 10, 138-143.
131. Enting, D.; van der Werf, T.S.; Prins, T.R.; Zijlstra, J.G.; Ligtenberg, J.J.; Tulleken, J.E. Massive haemoptysis: primary care, diagnosis and treatment. Ned. Tijdschr. Geneeskd. 2004, 148, 1582-1586.
132. Abe, Y.; Nakamura, M.; Suzuki, K.; Hashizume, T.; Tanigaki, T.; Saito, T.; Fujino, T.; Kikuchi, K. Massive hemoptysis due to Mycobacterium fortuitum infection controlled with bronchial artery embolization - a case report. Clin. Imag. 1999, 23, 361-363.
133. Parker, W.H. Etiology, symptomatology, and diagnosis of uterine myomas. Fert. Steril. 2007, 87, 725-736.
134. Munro, M.G.; Lukes, A.S. Abnormal Uterine Bleeding and Underlying Hemostatic Disorders Consensus Group. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process. Fert. Steril. 2005, 84, 1335-1337.
135. Wegienka, G.; Baird, D.D.; Hertz-Picciotto, I.; Harlow, S.D.; Steege, J.F.; Hill, M.C.; Schectman, J.M.; Hartmann, K.E. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet. Gynecol. 2003, 101, 431-437.
136. Lippman, S.A.; Warner, M.; Samuels, S.; Olive, D.; Vercellini, P.; Eskenazi, B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fert. Steril. 2003, 80, 1488-1494.
137. Dick, M.L. Chronic pelvic pain in women: assessment and management. Aust. Fam. Physician 2004, 33, 971-976.
138. Hosokawa, Y.; Kishino, T.; Ono, T.; Oyama, N.; Momose, H. Two cases of female acute urinary retention caused by an impacted pelvic mass. Int. J. Urol. 2005, 12, 1069-1070.
139. Barnacle, S.; Muir, T. Intermittent urinary retention secondary to a uterine leiomyoma. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2007, 18, 339-341.
140. Iavazzo, C.; Myriokefalitaki, E.; Vorgias, G.; Akrivos, T.; Lekka, I.; Katsoulis, M. Giant solid abdominal mass with cystic lesions: a case report and diaphorodiagnostic approach. Bratisl. Lek. Listy 2006, 107, 445-447.
141. Vilos, G.A. Uterine fibroids: relationships to reproduction. Minerva Ginecol. 2003, 55, 417-423.
142. Casini, M.L.; Rossi, F.; Agostini, R.; Unfer, V. Effects of the position of fibroids on fertility. Gynecol. Endocrinol. 2006, 22, 106-109.
143. Williams, V.S.; Jones, G.; Mauskopf, J.; Spalding, J.; DuChane, J. Uterine fibroids: a review of health-related quality of life assessment. J. Womens Health (Larchmt) 2006, 15, 818-829.
144. Myers, E.R.; Barber, M.D.; Gustilo-Ashby, T.; Couchman, G.; Matchar, D.B.; McCrory, D.C. Management of uterine leiomyomata: what do we really know? Obstet. Gynecol. 2002, 100, 8-17.
145. Kjerulff, K.H.; Langenberg, P.W.; Rhodes, J.C.; Harvey, L.A.; Guzinski, G.M.; Stolley, P.D. Effectiveness of hysterectomy. Obstet. Gynecol. 2000, 95, 319-326.
146. Hartmann, K.E.; Ma, C.; Lamvu, G.M.; Langenberg, P.W.; Steege, J.F.; Kjerulff, K.H. Quality of life and sexual function after hysterectomy in women with preoperative pain and depression. Obstet. Gynecol. 2004, 104, 701-709.
147. West, S.; Ruiz, R.; Parker, W.H. Abdominal myomectomy in women with very large uterine size. Fert. Steril. 2006, 85, 36-39.
148. Muñoz, J.L.; Jiménez, J.S.; Hernández, C.; Vaquero, G.; Pérez Sagaseta, C.; Noguero, R.; Miranda, P.; Hernández, J.M.; De la Fuente, P. Hysteroscopic myomectomy: our experience and review. JSLS 2003, 7, 39-48.
149. Hurst, B.S.; Matthews, M.L.; Marshburn, P.B. Laparoscopic myomectomy for symptomatic uterine myomas. Fert. Steril. 2005, 83, 1-23.
150. Chwalisz, K.; Perez, M.C.; Demanno, D.; Winkel, C.; Schubert, G.; Elger, W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr. Rev. 2005, 26, 423-438.
151. Chavez, N.F.; Stewart, E.A. Medical treatment of uterine fibroids. Clin. Obstet. Gynecol. 2001, 44, 372-384.
152. Yoon, W. Embolic agents used for bronchial artery embolization in massive haemoptysis. Expert Opin. Pharmacother. 2004, 5, 361-367.
153. Weichert, W.; Denkert, C.; Gauruder-Burmester, A.; Kurzeja, R.; Hamm, B.; Dietel, M.; Kroencke, T.J. Uterine arterial embolization with tris-acryl gelatin microspheres. Am. J. Surg. Pathol. 2005, 29, 955-961.
154. Lewis, A.L.; Gonzalez, M.V.; Leppard, S.W.; Brown, J.E.; Stratford, P.W.; Phillips, G.J.; Lloyd, A.W. Doxorubicin eluting beads-1: effects of drug loading on bead characteristics and drug distribution. J. Mater. Sci. Mater. Med. 2007, 18, 1691-1699.
155. Gonzalez, M.V.; Tang, Y.; Phillips, G.J.; Lloyd, A.W.; Hall, B.; Stratford, P.W.; Lewis, A.L. Doxorubicin eluting beads-2: methods for evaluating drug elution and in vitro:in vivo correlation. J. Mater. Sci. Mater. Med. 2008, 19, 767-775.
156. Bratby, M.J.; Belli, A.M. Radiological treatment of symptomatic uterine fibroids. Best Pract. Res. Clin. Obstet. Gynaecol. 2008, 22, 717-734.
157. Patel, Z.S.; Young, S.; Tabata, Y.; Jansen, J.A.; Wong, M.E.K.; Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43, 931-940.
158. Lewis, A.L.; Gonzalez, M.V.; Lloyd, A.W.; Hall, B.; Tang, Y.; Willis, S.L.; Leppard, S.W.; Wolfenden, L.C.; Palmer, R.R.; Stratford, P.W. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J. Vasc. Interven. Radiol. 2006, 17, 335-342.
159. Nitta, N.; Ohta, S.; Tanaka, T.; Takazakura, R.; Toyama, T.; Sonoda, A.; Seko, A.; Furukawa, A.; Takahashi, M.; Murata, K.; Kurumi, Y.; Tani, T.; Sakamoto, T.; Tabata, Y. An initial clinical study on the fficacy of cisplatinpreleasing gelatin microspheres for metastatic liver tumors. Eur. J. Radiol. 2009, 71, 519-526.
160. Yan, X.; Gemeinhart, R.A. Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles. J. Control. Release2005, 106, 198-208.
161. Hovsepian, D.M.; Mandava, A.; Pilgram, T.K.; Holder A.P.; Wong, V.; Chan, P.; Patel, T. Comparison of adjunctive use of rofecoxib versus ibuprofen in the management of postoperative pain after uterine artery embolization. J. Vasc. Interven. Radiol. 2006, 17, 665-670.
162. Borovac, T.; Pelage, J.P.; Kasselouri, A.; Prognon, P.; Guiffant, G.; Laurent, G. Release of ibuprofen from beads for embolization: in vitro and in vivo studies. J. Control. Release2006, 115, 266-274.
163. Wassef, M.; Pelage, J.P.; Velzenberger, E.; Namur, J.; Schwartz-Cornil, I.; Taylor, R.R.; Lewis, A.L.; Laurent, G. Anti-inflammatory effect of ibuprofen-loaded embolization beads in sheep uterus. J. Biomed. Mater. Res. Part B. Appl. Biomater. 2008, 86B, 63-73.
164. Fu, X.; Ping, Q.; Gao, Y. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J. Microencapsul. 2005, 22, 705-714.
165. Hamishehkar, H.; Emami, J.; Najafabadi, A.R.; Gilani, K.; Minaiyan, M.; Mahdvi, H.; Nokodchi, A. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf. B 2009, 74, 340-349.
166. Raman, C.; Berkland, C.; Kim, K.; Pack, D.W. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and non-uniform drug distribution. J. Control. Release2005, 103, 149-158.
167. Berchane, N.S.; Carson, K.H.; Rice-Ficht, A.C.; Andrews, M.J. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory. Int. J. Pharm. 2007, 337, 118-126.
168. Berchane, N.; Jebrail, F.F.; Andrews, M.J. Optimization of PLG microspheres for tailored drug release. Int. J. Pharm. 2010, 383, 81-88.
169. Berchane, N.S.; Jebrail, F.F.; Carson, K.H.; Rice-Ficht, A.C., Andrews, M.J. About mean diameter and size distributions of poly(lactide-co-glycolide) [PLG] microspheres. J. Microencapsul. 2006, 23, 539-552.
170. Dawes, G.J.S.; Fratila-Apachitie, L.E.; Mulia, K.; Apachitie, I.; Witkamp, G.J.; Duszczyk, J. Size effect of PLGA spheres on drug loading efficiency and release profiles. J. Mater. Sci. Mater. Med. 2009, 20, 1089-1094.
171. Sivakumar, M.; Pandurangarao, K. In vitro release of ibuprofen and gentamicin from PMMA functional microspheres. J. Biomater. Sci. Polym. Ed. 2002, 13, 111-126.